NCT01392911
Safety, Tolerability, Extended Early Bactericidal Activity and PK of Higher Doses Rifampicin in Adults With Pulmonary TB treatment 2 completed NCT01698476
Immune Reconstitution in Tuberculosis Disease treatment 2 completed NCT06058299
Phase 2 Trial Assessing TBAJ876 or Bedaquiline, with Pretomanid and Linezolid in Adults with Drug-sensitive Pulmonary Tuberculosis treatment 2 active_not_recruiting NCT05221502
Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB treatment 2 completed NCT04645836
Impact of a Pharmacist-led Patient-centred Care Intervention Along With Text-Message Reminders, on the Management of Newly Diagnosed Tubercular Patients: a Protocol for a Randomized Controlled Trial'. No drug interventions health_services_research Not Available completed NCT05426720
Risk Factors and Biomarkers for Post-tuberculosis Lung Damage No drug interventions Not Available Not Available recruiting NCT02961569
Comparison Between Two Strategies for the Diagnosis of TB No drug interventions diagnostic Not Available completed NCT00212550
Evaluation of the Practice of Three Morning Sputa on Separate Days for Diagnosis of Mtb No drug interventions Not Available Not Available completed NCT00933790
Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis treatment 3 completed NCT04264221
Promoting Overall Care and Management Related to Tuberculosis Infection Through Pharmaceutical Care and Text Messaging No drug interventions health_services_research Not Available unknown_status NCT03678688
A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis treatment 1 / 2 completed NCT03025516
Performance Evaluation of TB Breath- and Cough-testing Platforms No drug interventions Not Available Not Available unknown_status NCT03722472
Phase 1 Clinical Trial of Single-Vial ID93 + GLA-SE in Healthy Adults prevention 1 completed NCT06253715
Shortened Regimen for Drug-susceptible TB in Children treatment 3 not_yet_recruiting NCT05007821
Linezolid Dosing Strategies in Drug-Resistant TB treatment 2 active_not_recruiting NCT05526911
A Phase 1, Drug-Drug Interaction Study of TBAJ-876 in Healthy Adults treatment 1 completed NCT06624501
Integrated Discovery and Development of Innovative TB Diagnostics No drug interventions Not Available Not Available completed NCT06084715
The INSTITUT Study No drug interventions Not Available Not Available recruiting NCT06441006
Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis treatment 3 not_yet_recruiting NCT05190146
Epidemiologic Study to Assess the IGRA Positivity in Populations With a High TB Burden No drug interventions Not Available Not Available active_not_recruiting NCT06608069
Pharmacist-Led Intervention to Improve TB Treatment and Outcomes No drug interventions supportive_care Not Available recruiting NCT05215990
Efficacy of Metformin for Sputum Conversion in Patients With Active Pulmonary Tuberculosis treatment 1 / 2 unknown_status NCT05889364
AI-based System for Lung Tuberculosis Screening: Diagnostic Accuracy Evaluation No drug interventions Not Available Not Available active_not_recruiting NCT03220464
Early Diagnosis of Active Tuberculosis Using Ultra Low-dose Chest CT No drug interventions screening Not Available unknown_status NCT06526221
Evaluating Urine Isoniazid Testing to Detect Nonadherence to Tuberculosis Medications in India No drug interventions health_services_research Not Available not_yet_recruiting NCT05285202
Clinic-based Versus Hotspot-focused Active TB Case Finding No drug interventions screening Not Available recruiting NCT00567151
Co-Infection of NTM in Patients With Smear Positive Pulmonary TB No drug interventions Not Available Not Available completed NCT05454345
Sitafloxacin-containing Regimens for Shortening Tuberculosis Treatment treatment 3 not_yet_recruiting NCT01945905
Cost-effectiveness of Two Forms of DOTS in a Demonstration Area of the DOTS Strategy in Colombia No drug interventions health_services_research Not Available completed NCT04493671
Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults treatment 1 completed NCT05401071
Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T) No drug interventions treatment 2 / 3 recruiting NCT04973371
Acceptability and Feasibility of Home-based TB Testing No drug interventions screening Not Available completed NCT02901288
Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis treatment 4 unknown_status NCT04766307
A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2 treatment 4 unknown_status NCT03416309
Personalization of AntiTB Treatment: Evaluation of Pharmacological Determinants of Treatment Response No drug interventions Not Available Not Available unknown_status NCT02768909
Diagnostic Trial to Validate the Use of the E-Nose in Pulmonary TB No drug interventions diagnostic Not Available unknown_status NCT00140309
TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment treatment 2 completed NCT04485156
Treatment Shortening of Drug-Sensitive Pulmonary Tuberculosis Using High Dose Rifampicin (Hi-DoRi-3) treatment 3 not_yet_recruiting NCT05236452
Effect of Integrating Traditional Tuberculosis Care With Modern Health Care on Case Detection No drug interventions treatment Not Available completed NCT03590600
A Single Ascending Dose Study of BTZ043 treatment 1 completed NCT03776500
Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PBTZ169 in Multiple Dosing treatment 1 completed NCT04995406
Validating the Use of Blood Transcriptomic Signatures for the Diagnosis of Active Pulmonary Tuberculosis No drug interventions Not Available Not Available completed NCT04865536
Study to Evaluate Safety, Tolerability, and the PK Profile of TBI-223 in Healthy Subjects treatment 1 completed NCT00939419
The Effectiveness of Health Facility-based and Community-based Care for Tuberculosis No drug interventions treatment 4 completed NCT01218217
Early Bactericidal Activity (EBA) of SQ109 in Adult Subjects With Pulmonary TB treatment 2 completed NCT05122624
A Clinical Risk Score for Early Management of TB in Uganda No drug interventions diagnostic Not Available completed NCT03251196
TB Sequel: Pathogenesis and Risk Factors of Long-term Sequelae of Pulmonary TB No drug interventions Not Available Not Available unknown_status NCT04938596
Airborne Preventive Measures to Reduce New TB Infections in Household Contacts No drug interventions prevention Not Available completed NCT03044158
GeneXpert Performance Evaluation for Linkage to Tuberculosis Care No drug interventions diagnostic Not Available completed NCT04968886
TuBerculosis Viability Interregional Study and Agreement on Biological Tests No drug interventions Not Available Not Available unknown_status NCT03086486
Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis treatment 3 completed NCT04694586
Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and Pyrazinamide treatment 2 suspended NCT01785186
Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design treatment 2 completed NCT04919239
Clinical Trial to Investigate Therapeutic Vaccine (RUTI) Against Tuberculosis (TB) No drug interventions treatment 2 active_not_recruiting NCT00495339
MDR TB, Levofloxacin, Multi-Drug-Resistant Pulmonary Tuberculosis treatment 4 completed NCT03199339
A Phase 1 Study to Evaluate Safety, Tolerability, PK, and PK Interactions of TBA-7371 treatment 1 completed NCT06526039
A Short Regimen for Rifampicin-resistant Isoniazid-susceptible TB No drug interventions treatment 3 not_yet_recruiting NCT03728725
Xpert MTB/XDR Clinical Evaluation Trial No drug interventions Not Available Not Available completed NCT03423030
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Ex-vivo Antitubercular Activity of PBTZ169 Formulation treatment 1 completed NCT03862248
Novel Triple-dose Tuberculosis Retreatment Regimens: How to Overcome Resistance Without Creating More treatment 3 withdrawn NCT04874948
Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment treatment 1 completed NCT05640648
Human-centered Design and Communities of Practice to Improve Delivery of Home-based Tuberculosis Contact Investigation in Uganda No drug interventions screening Not Available completed NCT03281226
RIPE vs RIPE Plus N-acetylcysteine in Patients With HIV/TB Co-infection No drug interventions treatment 2 unknown_status NCT05926466
BTZ-043 Dose Evaluation in Combination and Selection treatment 2 recruiting NCT02967666
Evaluation of PET/MRI Using a Somatostatin Analog Tracer as a Novel Approach to Detecting Pathology in High Risk TB-exposed Contacts No drug interventions diagnostic 1 unknown_status NCT02589782
Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s) treatment 2 / 3 completed NCT03072576
Accuracy and Feasibility of Xpert Ultra No drug interventions Not Available Not Available completed NCT00685360
A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB) treatment 2 completed NCT06409780
Comparative Efficacy of CUS, CXR and CAD in TB Diagnosis in LMIC No drug interventions diagnostic Not Available not_yet_recruiting NCT03028129
Prevention of Tuberculosis in Prisons prevention 4 terminated NCT06205589
Therapeutic ID93 + GLA-SE Vaccination in Participants With Rifampicin-Susceptible Pulmonary TB treatment 2 not_yet_recruiting NCT04752592
Evaluation of a Rapid Point-of-Care Serological Triage Test for Active TB No drug interventions diagnostic Not Available recruiting NCT00004444
Pilot Randomized Study of Paromomycin (Aminosidine) vs Streptomycin for Uncomplicated Pulmonary Tuberculosis treatment Not Available completed NCT05766267
Short-course Regimens for the Treatment of Pulmonary Tuberculosis treatment 2 / 3 recruiting NCT04150367
Efficacy and Safety of Intravenous Treatment of Tuberculosis Not Available Not Available terminated NCT05664568
The BLAST- 1 Trial - Cephalexin+Amoxicillin-clavulanate for Tuberculosis treatment 2 recruiting NCT00419068
Trial of Adjunctive Vitamin D in Tuberculosis Treatment treatment 3 completed NCT00054769
Diagnosing Tuberculosis in HIV Infected Children in Peru No drug interventions Not Available Not Available completed NCT05556746
Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible TB treatment 2 recruiting NCT05981495
Clinical Evaluation of the NanoDetect-TB Mycobacterium Tuberculosis Detection Kit for the Diagnosis of Tuberculosis Disease No drug interventions Not Available Not Available not_yet_recruiting NCT05539014
Tuberculosis Cohort Avicenne Hospital No drug interventions Not Available Not Available recruiting NCT03732014
Bronchial Washings in Sputum Scarce Cases of Pulmonary Tuberculosis No drug interventions Not Available Not Available withdrawn NCT05047055
Four Months Moxifloxacin Containing Daily Regimen Study Among New Pulmonary Tuberculosis Patients Not Available Not Available active_not_recruiting NCT02776150
Probe Melting Technology for Rapid Detection of Drug Resistant Tuberculosis No drug interventions Not Available Not Available unknown_status NCT06159023
Conventional Bronchoscope With BAL vs. Thin Bronchoscope With BW to Diagnose Pulmonary TB No drug interventions diagnostic Not Available recruiting NCT04682990
DIAGNOSIS of PULMONARY TUBERCULOSIS Through HUMAN BREATH (TBENOSE) No drug interventions diagnostic Not Available completed NCT03338621
Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients treatment 2 / 3 completed NCT04844502
Cardiopulmonary Function and Quality of Life in Pulmonary Tuberculosis No drug interventions treatment Not Available recruiting NCT03174184
Early Bactericidal Activity of Rifampin + Meropenem + Amoxicillin/Clavulanate in Adults With Pulmonary TB treatment 2 completed NCT04055584
PCR Techniques of Dried Sputum Using a Spotcard No drug interventions Not Available Not Available unknown_status NCT03547479
VDOT and Mobile Payments in Cambodia No drug interventions health_services_research Not Available withdrawn NCT03478033
Rifampicin vs Rifabutin in HIV/AIDS Patients Combined With Tuberculosis treatment Not Available unknown_status NCT01395654
Reintroduction Regimens After Hepatitis During Anti-tuberculosis Treatment treatment 4 unknown_status NCT03967353
Study on the Management Model of "Home Treatment" for Tuberculosis Patients No drug interventions treatment Not Available unknown_status NCT05258877
Pharmacokinetics of Ethionamide and Ethionamide Sulfoxide in Patients Established on Treatment for Tuberculosis. No drug interventions Not Available Not Available completed NCT03474198
Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive Tuberculosis treatment 2 / 3 completed NCT05065905
Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and Tuberculosis treatment 1 / 2 completed NCT02972697
Evaluation of 11C-acetate PET Imaging as a Novel Approach to Detecting Pathology in Pulmonary TB No drug interventions diagnostic 1 unknown_status NCT02153528
Optimization of the TB Treatment Regimen Cascade No drug interventions treatment 3 completed NCT01130311
Replacement of Vitamin D in Patients With Active Tuberculosis supportive_care Not Available completed NCT02715271
Study of TB Lesions Obtained in Therapeutical Surgery No drug interventions Not Available Not Available active_not_recruiting NCT03712709
Clinical Evaluation of the Truenat Point-of-care Tuberculosis Diagnostic Test No drug interventions Not Available Not Available completed NCT03822156
Clinical Analysis of the Patients With Cavitary Pulmonary TB and Endobronchial TB in the PPM-UUH Cohort No drug interventions Not Available Not Available completed NCT05048485
Tuberculosis - Learning the Effect of Parasites and Reinforcing Diets No drug interventions Not Available Not Available enrolling_by_invitation NCT06477185
Characterization of Tuberculosis Associated Lung Fibrosis and Respiratory Impairment, and Prevention Using Doxycycline treatment 2 not_yet_recruiting NCT04734652
INSTI's For The Management of HIV-associated TB treatment 2 active_not_recruiting NCT04179500
A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis Volunteers treatment 2 active_not_recruiting NCT05899400
A Study to Validate and Improve an Automated Image Analysis Algorithm to Detect Tuberculosis in Sputum Smear Slides No drug interventions Not Available Not Available completed NCT04079400
Microbiome in Pulmonary Tuberculosis, Non-tuberculous Mycobacterial Pulmonary Diseases, Lung Cancer and Hemoptysis No drug interventions Not Available Not Available completed NCT03302949
Treating Tuberculosis Wasting With a High-protein Supplement No drug interventions treatment Not Available terminated NCT03512249
Study to Evaluate H56:IC31 in Preventing Rate of TB Recurrence No drug interventions prevention 2 active_not_recruiting NCT03199313
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid treatment 1 completed NCT04232618
Point-of-care Triage Test for Active Tuberculosis No drug interventions Not Available Not Available unknown_status NCT04575519
Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis treatment 2 recruiting NCT06057519
Pragmatic Optimized Rifampicin Trial treatment 3 recruiting NCT01525134
Feasibility of a Lateral Flow Urine Lipoarabinomannan (LAM) Test for Diagnosis of Tuberculosis No drug interventions diagnostic Not Available unknown_status NCT01364324
Pharmacokinetics of Anti-tuberculosis Drugs in Gastrectomized Patients Not Available Not Available completed NCT01693224
Feasibility of a Lateral Flow Urine LAM Test for Diagnosis of Tuberculosis in South Africa No drug interventions diagnostic Not Available unknown_status NCT03941496
Azacytidine During Anti-tuberculosis Therapy treatment 1 / 2 withdrawn NCT06585358
DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary Tuberculosis No drug interventions Not Available Not Available not_yet_recruiting NCT01162486
Pharmacokinetics, Safety and Tolerability of Escalating Rifapentine Doses in Healthy Volunteers treatment 1 completed NCT04147286
Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion treatment 2 / 3 recruiting NCT03519425
A Pragmatic Randomised Study to Optimise Screening, Prevention and Care for Tuberculosis in Malawi No drug interventions health_services_research Not Available unknown_status NCT05325125
Childhood TB Sequel No drug interventions Not Available Not Available recruiting NCT05388448
EBA, Safety and Tolerability of Sanfetrinem Cilexetil treatment 2 unknown_status NCT01381757
Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali No drug interventions Not Available Not Available terminated NCT05477966
A Retrospective Cohort Study to Develop Markers for TB Severity and Treatment Progress No drug interventions Not Available Not Available unknown_status NCT05073965
Vitamin D Supplementation Effect In Children With Pulmonary Tuberculosis Treatment No drug interventions supportive_care Not Available completed NCT01638520
Safety and Efficacy of Blocking IL-4 With Pascolizumab in Patients Receiving Standard Therapy for Pulmonary Tuberculosis treatment 2 unknown_status NCT05756582
Prevalence of Latent Tuberculosis Infection in Health-care Workers and Students No drug interventions Not Available Not Available recruiting NCT04783727
PredictEndTB Signature for Individualizing Treatment in Multidrug-Resistant Tuberculosis No drug interventions treatment Not Available terminated NCT06392594
Performance of Xpert MTB/RIF and XDR Assay for Diagnosis of Pulmonary Tuberculosis and Resistant Pulmonary TB No drug interventions Not Available Not Available not_yet_recruiting NCT05268380
Collision of Three Global Pandemics: the Effect of Tuberculosis and HIV on the Epidemiological, Clinical, Virological and Immunological Trajectory of COVID-19 in Botswana and Namibia No drug interventions Not Available Not Available recruiting NCT04856644
Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TB treatment 3 active_not_recruiting NCT03271567
Nanodisk-MS Assay for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis in Hospitalized Patients No drug interventions Not Available Not Available completed NCT02653404
IGRA and Mantoux Response in Children With Suspected Latent or Active TB Infection No drug interventions Not Available Not Available unknown_status NCT04122404
POC Strategies to Improve TB Care in Advanced HIV Disease No drug interventions diagnostic Not Available completed NCT04074369
Evaluation of CRISPR-based Test for the Rapid Identification of TB in Pulmonary Tuberculosis Suspects No drug interventions Not Available Not Available unknown_status NCT04848246
Effect of Smoking Cessation on Tuberculosis Treatment Outcomes supportive_care Not Available completed NCT06171646
Effect of Breathing Exercise on Fatigue in Patients With Pulmonary Tuberculosis No drug interventions supportive_care Not Available completed NCT03758612
A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of TBI-223 in Healthy Adults treatment 1 completed NCT05455112
Safety and Efficacy of RUTI® With the Standard of Treatment for Tuberculosis treatment 2 recruiting NCT04721795
Treating Tuberculosis With the Lipid Lowering Drug Atorvastatin in Nigeria(ATORvastatin in Pulmonary TUBerculosis) treatment 2 / 3 completed NCT03160638
Azithromycin as Host-directed Therapy for Pulmonary Tuberculosis treatment 2 completed NCT03702738
Adjunctive NAC in Adult Patients With Pulmonary Tuberculosis treatment 2 unknown_status NCT06114628
Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB treatment 2 recruiting NCT06528418
Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath No drug interventions Not Available Not Available recruiting NCT06649721
Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese Cohort No drug interventions treatment 3 not_yet_recruiting NCT05971602
Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis treatment 2 active_not_recruiting NCT00834353
Prospective Study of N-acetyltransferase2 (NAT2) and Cytochrome P4502E1 (CYP2E1) Gene as Susceptible Risk Factors for Antituberculosis (ATT) Induced Hepatitis Not Available Not Available completed NCT00571753
Isoniazid Dose Adjustment According to NAT2 Genotype (IDANAT2) treatment 3 terminated NCT00948077
Pharmacokinetic Study for Anti-tuberculosis Drugs Not Available Not Available unknown_status NCT04081077
PRACTECAL-PKPD Sub Study treatment 2 / 3 unknown_status NCT00864383
Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis treatment 3 completed NCT02464683
Effect of Vitamin D as Adjunctive Therapy in Patients With Pulmonary Evolution Tuberculosis No drug interventions treatment 4 unknown_status NCT06081361
Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort treatment 3 recruiting NCT04666311
Diagnostic Accuracy of CAD4TB and C-reactive Protein Assay as Triage Tests for Pulmonary Tuberculosis No drug interventions Not Available Not Available completed NCT01580007
Clinical Trial of Phenylbutyrate and Vitamin D in Tuberculosis (TB) treatment 2 completed NCT02331056
Could the Stroke Volume Variation Predict a Fluid Responsiveness in Thoracotomy? No drug interventions Not Available Not Available completed NCT02821832
Using Biomarkers to Predict TB Treatment Duration treatment 2 completed NCT01927159
Phase 1 ID93 + GLA-SE Vaccine Trial in BCG-Vaccinated Healthy Adult Volunteers prevention 1 completed NCT02279875
A Phase 2 Trial to Evaluate the Efficacy and Safety of Linezolid in Tuberculosis Patients. (LIN-CL001) treatment 2 completed NCT01002170
Pharmacokinetic Study of Patients Who Undergo Cycloserine, a 2nd-line Antituberculosis Medicament No drug interventions Not Available Not Available completed NCT02381470
Trial of Faropenem and Cefadroxil (in Combination With Amoxicillin/Clavulanic Acid and Standard TB Drugs) in Patients With Pulmonary Tuberculosis: Measurement of Early Bactericidal Activity and Effects on Novel Biomarkers treatment 2 completed NCT00298870
Randomized Trial for Pharmacogenomics-based Tuberculosis Therapy (RT-PGTT) treatment 4 completed NCT02169570
Effect of Supplementary Vitamin D in Patients With Diabetes Mellitus and Pulmonary Tuberculosis No drug interventions treatment 4 unknown_status NCT03277742
Joint Management of DM2 and Pulmonary TB in Orizaba, Veracruz No drug interventions treatment Not Available withdrawn NCT02333799
A Phase 3 Study Assessing Safety and Efficacy of Bedaquiline Plus PA-824 Plus Linezolid in Subjects With Drug Resistant Pulmonary Tuberculosis treatment 3 completed NCT05807399
PanACEA - STEP2C -01 treatment 2 recruiting NCT02554318
Fermented Soybean Supplementation Among Active Pulmonary Tuberculosis Patients With Standard Therapy in Indonesia supportive_care Not Available completed NCT04055441
A Study of Pattern of Presentation of Pulmonary Tuberculosis Patients Undergoing Treatment at Assiut University Hospital No drug interventions Not Available Not Available unknown_status NCT06127641
Rehabilitation of People With Post-tuberculosis Lung Disease No drug interventions treatment Not Available recruiting NCT06157034
Prokinetic Effect of Selected Nutraceuticals No drug interventions treatment Not Available completed NCT00057434
Vitamin A Therapy for Tuberculosis No drug interventions treatment 3 completed NCT01691534
Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With Clofazimine (C)-TMC207 (J)-PA-824 (Pa)-Pyrazinamide (Z) treatment 2 completed NCT02465216
Phase 2a ID93 + GLA-SE Vaccine Trial in TB Patients After Treatment Completion prevention 2 completed NCT00023335
TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis treatment 3 completed NCT02106039
Pulmonary Tuberculosis Patients With Diabetes Mellitus No drug interventions treatment Not Available completed NCT03959566
PanACEA Sutezolid Dose-finding and Combination Evaluation treatment 2 completed NCT02581527
A Randomised Trial to Evaluate Toxicity and Efficacy of 1200mg and 1800mg Rifampicin for Pulmonary Tuberculosis treatment 3 completed NCT06192160
Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis treatment 2 not_yet_recruiting NCT00694629
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment treatment 2 completed NCT01242592
Homeopathy as an Adjuvant to Chemotherapy Improves Clinical Outcome in Relapsed Pulmonary Tuberculosis treatment 2 completed NCT04930744
Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) treatment 2 recruiting NCT00567840
PA-824-CL-007: Phase IIa Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis treatment 2 completed NCT01215110
Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (TMC207-CL001) treatment 2 completed NCT06476210
The Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis (MDR-TB) or Rifampicin-Resistant Tuberculosis (RR-TB) No drug interventions treatment 4 recruiting NCT02371681
NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis No drug interventions treatment 2 completed NCT04857814
Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From Wearable Devices in Respiratory Diseases No drug interventions diagnostic Not Available completed NCT04608955
Evaluation of Early Bactericidal Activity and Safety in Pulmonary Tuberculosis With WX-081 treatment 2 completed NCT04176250
Early Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis treatment 2 completed NCT02467608
Efficacy of HUEXC030 in Subjects With Pulmonary Tuberculosis treatment 2 / 3 completed NCT00772408
Toll-like Receptor 2 Gene Polymorphism, Serum Cytokines and Susceptibility to Disease Severity or Treatment Response of Pulmonary Tuberculosis No drug interventions Not Available Not Available completed NCT02736864
Structural and Functional Repercussions of Pulmonary Tuberculosis Sequelae No drug interventions Not Available Not Available completed NCT06199921
ATORvastatin in Pulmonary TUBerculosis treatment 2 recruiting NCT00944021
Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (CL-010) treatment 2 completed NCT06110533
Epidemiological Study of Hospitalized Children for Pulmonary Tuberculosis at Strasbourg University Hospitals No drug interventions Not Available Not Available recruiting NCT04504851
Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct treatment 2 unknown_status NCT01215851
Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With(J-M-Pa-Z) (NC-001) treatment 2 completed NCT04260477
Novel Triple-dose Tuberculosis Retreatment Regimen treatment 3 active_not_recruiting NCT03882177
StAT-TB (Statin Adjunctive Therapy for TB): A Phase 2b Dose-finding Study of Pravastatin in Adults With Tuberculosis treatment 2 completed NCT01599897
Phase 1 ID93 + GLA-SE Vaccine Trial in Healthy Adult Volunteers prevention 1 completed NCT02836483
A Phase II Clinical Study of LCB01-0371 to Evaluate the EBA, Safety and PK treatment 2 completed NCT00401271
Safety, Efficacy and Pharmacokinetics of OPC-67683 in Patients With Pulmonary Tuberculosis treatment 2 completed NCT00001407
Interferon Gamma for Drug Resistant Tuberculosis treatment 2 completed NCT05359315
Study on the Use of Interferon Gamma (Ingaron) Injections in Patients With Drug-resistant Pulmonary Tuberculosis Not Available Not Available unknown_status NCT04550832
PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE) treatment 2 completed NCT02912832
Prospective Assessment of TBDx Feasibility No drug interventions diagnostic Not Available completed NCT01154959
Latency in Pulmonary Tuberculosis treatment 3 completed NCT00366470
A Clinical Trial to Study the Effect of the Addition of Vitamin D to Conventional Treatment in New Pulmonary Tuberculosis Patients treatment 3 completed NCT02558842
Intervention in the Management of Post-high Tuberculosis Hospital Through Educational Strategy and Oversight Distance No drug interventions Not Available Not Available completed NCT01503099
Intestinal Tuberculosis Diagnostics and the Differentiation From Crohn's Disease No drug interventions Not Available Not Available unknown_status NCT04236349
Tuberculosis Cohort in the North of Paris No drug interventions Not Available Not Available unknown_status NCT05148949
Study on Three Doses of an Inactivated COVID-19 Vaccine in Chinese Pulmonary Tuberculosis Patients prevention 4 unknown_status NCT01498419
Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002) treatment 2 completed NCT02349841
Phase 2 Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of Meropenem Plus Amoxycillin/CA and Faropenem Plus Amoxycillin/CA in Adult Patients With Newly Diagnosed Pulmonary Tuberculosis treatment 2 completed NCT02256696
Assessing PA-824 for Tuberculosis (the APT Trial) treatment 2 completed NCT00698386
Efficacy of Oral Zinc Administration as an Adjunct Therapy in New Pulmonary Tuberculosis (Category I) Patients No drug interventions treatment 3 unknown_status NCT01618422
Directly Observed Therapy Short Course-Plus Versus DOTS for Retreatment of Relapsed Pulmonary Tuberculosis in Guangzhou No drug interventions treatment Not Available completed NCT00803322
Improving Community Based Tuberculosis Care in Ethiopia No drug interventions Not Available Not Available completed NCT05896930
Study to Evaluate EBA, Safety and Tolerability of Carbapenems in Adults With Pulmonary Tuberculosis other 2 completed NCT03350048
Evaluation of Host Biomarker-based Point-of-care Tests for Targeted Screening for Active TB No drug interventions Not Available Not Available completed NCT01379066
Tuberculosis Volatile Organic Compounds No drug interventions Not Available Not Available completed NCT05046366
Development of an Artificial Intelligence System for Intelligent Pathological Diagnosis and Therapeutic Effect Prediction Based on Multimodal Data Fusion of Common Tumors and Major Infectious Diseases in the Respiratory System Using Deep Learning Technology. No drug interventions Not Available Not Available recruiting NCT00517231
Cytokines and Acute Phase Reactants as Markers of Pulmonary Tuberculosis Treatment No drug interventions Not Available Not Available withdrawn NCT02053129
Evaluation of PTB Screening in ANC in Lusaka, Zambia No drug interventions diagnostic Not Available completed NCT00727844
Linezolid to Treat Extensively-Drug Resistant Tuberculosis treatment 2 completed NCT00926601
Prevalence and Clinical Significance of Co-infection of Mycoplasma Pneumoniae in Patients With Pulmonary Tuberculosis No drug interventions Not Available Not Available unknown_status NCT04187469
Efficacy and Safety of Isoniazid, Rifampicin and Moxifloxacin for the Intensive Phase of Initial Therapy of PTB treatment Not Available unknown_status NCT02313610
Efficacy and Safety of Qinbudan as an Adjunct Therapy for Retreatment Pulmonary Tuberculosis No drug interventions treatment 2 completed NCT01011543
Induced Sputum Versus Bronchoscopy in Smear Negative Pulmonary Tuberculosis No drug interventions diagnostic Not Available completed